Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on X:
“Cowabunga!
Riding Breast Cancer’s Biggest Data’s Wave
New ASCO guidelines say we can SKIP SLNB in many early breast cancers!
SOUND and INSEMA trials show it’s safe for postmenopausal Wives with ER+/HER2- tumors ≤2cm and normal ultrasound.
Less surgery, same outcomes!”
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update
Authors: Ko Un Park, et al.
More posts featuring Armando Orlandi.